Limo, Mark L.
HRN: 21-40-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/26/2022
06/01/2022
IVT
740mg
Q6
UTI, PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes